Detalhe da pesquisa
1.
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 22(1D): e240001, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244272
2.
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(1): 67-81, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652935
3.
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(12): 1281-1301, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38081133
4.
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.
J Natl Compr Canc Netw
; 20(1): 8-19, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991075
5.
Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long- Term Follow-Up.
Biol Blood Marrow Transplant
; 26(1): 44-49, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31518644
6.
Diffuse "background" monoclonal light chain staining on kidney biopsies in the absence of electron-dense deposits - putting it into perspective: A retrospective cohort study.
Clin Nephrol
; 94(6): 307-317, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33094731
7.
Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myeloma.
Haematologica
; 108(12): 3477-3479, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439332
8.
Acute Promyelocytic Leukemia and Chronic Lymphocytic Leukemia: Concomitant Presentation of Two Molecularly Distinct Entities.
J La State Med Soc
; 169(3): 68-70, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28644154
9.
The Shreveport Myeloma Experience: Survival, Risk Factors and Other Malignancies in the Age of Stem Cell Transplantation.
Acta Haematol
; 135(3): 146-55, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26588024
10.
Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review.
J Geriatr Oncol
; 15(3): 101734, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430810
11.
Comparison of Patient Outcomes With Two Different Formulations of Melphalan as Conditioning Chemotherapy for Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 23(2): e85-e96, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36411211
12.
Outcomes After Salvage Autologous Hematopoietic Cell Transplant for Patients With Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience.
Clin Lymphoma Myeloma Leuk
; 23(3): e182-e189, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581554
13.
Survival outcomes following autologous stem cell transplant with melphalan 140mg/m2 versus 200mg/m2 preparative regimens in patients with multiple myeloma.
Leuk Lymphoma
; 64(7): 1315-1321, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199099
14.
Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma.
Front Oncol
; 13: 1216461, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37554170
15.
The first relapse in multiple myeloma: how to pick the next best thing.
Hematology Am Soc Hematol Educ Program
; 2022(1): 560-568, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36485087
16.
Early versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma.
J Clin Med
; 11(19)2022 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233663
17.
Improvement in Post-Autologous Stem Cell Transplant Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience.
Cancers (Basel)
; 14(9)2022 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35565406
18.
Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant.
Front Oncol
; 12: 801879, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35280722
19.
Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias.
Front Oncol
; 12: 858426, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35574379
20.
Role of Stem Cell Transplantation in Multiple Myeloma.
Cancers (Basel)
; 13(4)2021 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33670709